Peripheral Blood Mononuclear Cells Market to be Valued USD 268.58 Million by 2025
Growing utilization of peripheral blood mononuclear cells in
clinical and research applications to drive peripheral blood mononuclear cells
market
According to TechSci Research report, “Global Peripheral
Blood Mononuclear Cells Market By
Product, By Application, By Technique, By Source, By Region, Competition,
Forecast & Opportunities, 2025”, the global peripheral
blood mononuclear cells market was valued at 172.29 Million in 2019 and is
projected to grow at a CAGR of 8.46% during 2020 - 2025. PBMC are also called human
mononuclear cells from peripheral blood (HMNC-PB) and are made up of
lymphocytes & monocytes, and in humans, major composition of PBMC consists
of lymphocytes, followed by monocytes and dendritic cells. PBMC is crucial to
carry out the studies related to biology and pathology and are also quite
useful in clinical applications and research. Additionally, PMBCs help to find
characteristics which are important for research areas such as immunology,
transplant immunology, vaccine development, hematological malignancies, and
others. However, developing nations tend to lack research practices due to less
research institutes, which can eventually lead to less usage of PBMCs, thereby restraining
the market growth. test
Browse 156 Figures spread through 168 Pages and an
in-depth TOC on " Global Peripheral Blood Mononuclear Cells Market"
https://www.techsciresearch.com/report/peripheral-blood-mononuclear-cells-market/4561.html
The global peripheral blood mononuclear cells
market is segmented into product, application, technique, source, and region. Based
on product, the market is segmented into cryopreserved or frozen PBMC, cultured
or fresh PBMC and peripheral blood mononuclear cell isolation & viability
kits. Cryopreserved PBMC segment is expected to dominate the market during the
forecast period as frozen PBMC find wide application in clinical trials. Moreover,
PBMCs can be used for long durations of time if they are stored in a proper way
and at lower temperatures. They can even substitute fresh PBMCs in few
applications and thus, making it feasible for the scientists and researchers to
carry out various tests in one laboratory avoiding inter-laboratory issues. Based
on regional analysis, as of 2019, North America held the largest market share in
the global peripheral blood mononuclear cells market and the region is
anticipated to hold its position during the forecast period. This is majorly due
to the presence of pre-existing PBMC based research
organizations and lab service providers in the region.
Some
of the major players in the global peripheral blood mononuclear cells market include
Thermo Fisher Scientific Inc., Merck & Co., Inc., Corning Incorporate,
Bio-Rad Laboratories, Inc., Cellero, LLC, Life Technologies (India) Pvt. Ltd.,
Cell Applications, Inc., DAPCEL, Inc., Creative Bioarray, iXCells
Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL
Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, HemaCare
Corporation, BioVision, Inc., BioLegend, Inc., BioIVT LLC, Biopredic International,
Zen-Bio Inc., among others. In order to increase their market share, a rising
number of companies are adopting various strategies including collaborations to
attract more customers. For instance, Miltenyi Biotec, an European PBMC based
company, launched a new MACSprep PBMC Isolation Kit in June 14, 2017. The kit
is used for processing and diagnosis of small blood samples as it prepares
extremely pure PBMCs via the blood in a very short span of time without using
the procedure of centrifugation.
Download
Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=4561
Customers can also
request for 10% free customization on this report.
“Global
peripheral blood mononuclear cells market is anticipated to witness a formidable
growth over the course of next five years. Increase in number of diseases and
rise in number of PBMC based research organizations are some of the major
factors driving the market across the globe. Additionally, increasing incidents
of autoimmune and metabolic diseases are positively influencing the growth of
the market as PBMC is used in studies related to such diseases.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global
Peripheral Blood Mononuclear Cells Market By Product, By Application, By
Technique, By Source, By Region, Competition, Forecast & Opportunities,
2025” has evaluated the future growth potential of global peripheral
blood mononuclear cells market and provided statistics & information on
market size, shares, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges and opportunities in the
global peripheral blood mononuclear cells market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]